View Older Stories View More Recent Stories

Sep 2, 2020 10:20AM Absolute Named a Leader in the G2 Summer 2020 Grid Report for Endpoint Management
Sep 1, 2020 09:00AM Abbott's FreeStyle® Libre 2 iCGM System Now Available to Medicare Beneficiaries
Aug 27, 2020 06:39AM Abbott's (ABT) Fast, $5, 15-Minute, Easy-to-Use COVID-19 Antigen Test Receives FDA Emergency Use Authorization
Aug 26, 2020 06:30PM Abbott's Fast, $5, 15-Minute, Easy-to-Use COVID-19 Antigen Test Receives FDA Emergency Use Authorization; Mobile App Displays Test Results to Help Our Return to Daily Life; Ramping Production to 50 Mi
Aug 19, 2020 01:02PM Absolute Announces Filing of Shelf Prospectus
Aug 10, 2020 04:00PM Absolute Reports Fiscal 2020 Fourth Quarter and Annual Financial Results
Aug 4, 2020 09:05AM Abbott (ABT) Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation
Aug 4, 2020 09:00AM Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation
Aug 3, 2020 08:00AM Absolute Delivers New Platform Capabilities to Help Enterprises Meet Complex Compliance Requirements and Enable Autonomous, Self-Healing Endpoints
Jul 31, 2020 11:18AM Absolute to Present at the Canaccord Genuity 40th Annual Growth Conference
Jul 27, 2020 08:30AM Absolute to Host Conference Call for Fiscal 2020 Fourth Quarter and Annual Financial Results
Jul 23, 2020 09:05AM Abbott (ABT) Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
Jul 23, 2020 09:00AM Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
Jul 20, 2020 03:06PM Absolute Declares Quarterly Dividend
Jul 16, 2020 07:30AM Abbott Reports Second-Quarter 2020 Results, Exceeds Analysts' Expectations
Jul 13, 2020 04:18PM Abbott (ABT) Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences (EW)
Jul 13, 2020 04:15PM Abbott Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences
Jul 6, 2020 07:30AM Abbott (ABT) Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring
Jul 6, 2020 07:30AM Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring
Jun 30, 2020 08:19AM K-12 Education Sector Turns to Absolute for Successful Distance Learning Programs Rooted in Endpoint Resilience
Jun 29, 2020 09:07AM Abbott (ABT), Tandem Diabetes Care (TNDM) Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems
Jun 29, 2020 09:00AM Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems
Jun 26, 2020 09:00AM New Research Finds Abbott's Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages
Jun 25, 2020 10:03AM Abbott (ABT) Announces New Late-Breaking Data Highlight Impact of its Minimally Invasive Structural Heart Therapies
Jun 25, 2020 10:00AM New Late-Breaking Data Highlight Impact of Abbott's Minimally Invasive Structural Heart Therapies
Jun 25, 2020 08:00AM New Research from Absolute Underscores Vulnerability of Enterprise Devices and Critical Endpoint Controls, Reveals Opportunities to Optimize Security Investments
Jun 23, 2020 09:00AM Abbott Hosts Conference Call for Second-Quarter Earnings
Jun 18, 2020 08:00AM Absolute Expands Sensitive Data and Device Protections for Remote Endpoints with Enhancements to Undeletable Defense Platform
Jun 16, 2020 09:00AM New Data Show Use of Abbott's FreeStyle® Libre System Reduces All-Cause, Diabetic Ketoacidosis-Related Hospitalization Rates and Acute Diabetes Events
Jun 15, 2020 07:06AM Abbott (ABT) Reports FreeStyle Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes
Jun 15, 2020 07:01AM Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Jun 13, 2020 11:00AM New Late-Breaking Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1C Levels in People with Type 2 Diabetes Using Insulin or Not
Jun 12, 2020 10:28AM Abbott Declares 386th Consecutive Quarterly Dividend
Jun 10, 2020 08:00AM Anaheim Union High School District Protects Sizable Technology Investment with Absolute Endpoint Resilience
Jun 2, 2020 08:00AM Pennsylvania Cyber Charter School Selects Absolute to Protect Mission-Critical Apps With Unbreakable Endpoint Resilience
May 21, 2020 04:12PM Abbott (ABT) Releases Interim Clinical Study Data on ID NOW COVID-19 Rapid Test Showing Strong Agreement to Lab-Based Molecular PCR Tests
May 21, 2020 04:11PM Abbott Releases Interim Clinical Study Data on ID NOW COVID-19 Rapid Test Showing Strong Agreement to Lab-Based Molecular PCR Tests
May 21, 2020 02:57PM Absolute Honored as a Finalist in Two Categories for BC Tech Association’s 2020 Technology Impact Awards
May 21, 2020 02:19PM Abbott (ABT) Announces Contract to Supply Millions of IgG Lab-Based Antibody Tests to the UK Government
May 21, 2020 02:18PM Abbott Announces Contract to Supply Millions of IgG Lab-Based Antibody Tests to the UK Government
May 20, 2020 08:00AM Duarte Unified School District Protects Students While Fostering Student Engagement With Absolute Web Usage
May 20, 2020 08:00AM Absolute Powers K-12 Distance Learning Programs with the Launch of Web Usage
May 14, 2020 06:40PM Abbott Provides Update on ID NOW™
May 12, 2020 11:09AM Absolute to Present at 15th Annual Needham Virtual Technology & Media Conference
May 12, 2020 09:02AM Abbott (ABT) Receives FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity m System
May 12, 2020 09:00AM Abbott Receives FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity™ m System
May 11, 2020 04:12PM Absolute Reports Fiscal 2020 Third Quarter Financial Results
May 11, 2020 09:02AM Abbott (ABT) Receives FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity i System
May 11, 2020 09:00AM Abbott Receives FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity™ i System
May 8, 2020 09:02AM Abbott (ABT) Says Research from University of Washington Demonstrates High Performance of its SARS-CoV-2 Antibody Blood Test
View More Recent Stories View Older Stories